Semax side effects: what TikTok gets wrong about nasal irritation
Quick answer
The creator is stacking semax, a synthetic ACTH-derived peptide with dopaminergic and BDNF-related activity, with MK-677, a non-peptide ghrelin mimetic and GH secretagogue. They are reporting appetite suppression as a side effect of the stack and responding by self-escalating their MK-677 dose, a pharmacologically unsupported approach that raises concerns about insulin sensitivity and GH axis dysregulation. Neither compound is FDA-approved for the uses described, and this stack has no published safety data in healthy adults.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @rivi.rl actually say?
The creator claims they have been taking semax and describe it as "insane" for their sales performance, specifically crediting it with improved objection handling. They also mention they "have not been able to eat" and respond to this by deciding to "triple" their MK-677 dose, apparently reasoning that MK-677's appetite-stimulating reputation would counteract the appetite suppression they are experiencing. The video is casual and anecdotal, framed as a relatable complaint, but the decisions described carry real risks worth examining.
To be clear: the creator is not presenting themselves as a medical professional. They are a salesperson sharing personal experience. That context matters. But 13,000 views means a lot of people are hearing this as informal guidance, which is exactly why it deserves scrutiny.
Does the science back this up?
Semax's cognitive effects have actual research behind them, which is more than most nootropics can say. The appetite-suppression concern, however, is real and underreported. Tripling any secretagogue dose based on a self-diagnosed nutritional deficit is not a strategy supported by evidence.
Semax is a synthetic heptapeptide derived from ACTH(4-7). Russian research, including work by Bobyntsev et al. (2015, Bulletin of Experimental Biology and Medicine), has documented effects on BDNF expression and dopaminergic activity in animal models. Human data is thin but not nonexistent. Semax has been studied clinically in Russia for stroke recovery and attention tasks. The cognitive-performance angle is plausible, not proven in healthy adults doing sales calls.
MK-677 (ibutamoren) is a growth hormone secretagogue, not a peptide. It works by mimicking ghrelin and stimulating GH and IGF-1 release. Ghrelin is an appetite hormone, so MK-677 does typically increase appetite. But tripling a dose to overcome appetite suppression from a different compound is not how pharmacology works, and no published study supports that approach.
What did they get wrong (or right)?
Credit where it is due: semax's association with dopaminergic signaling and attention is genuinely supported in animal and some human literature. If the creator is noticing improved focus or verbal fluency, that is not implausible given semax's mechanism. They are not making something up from whole cloth.
What they got wrong is the improvised dose escalation. "I decided to triple my MK-dose" is the kind of sentence that should come with a lot more context than a TikTok caption. MK-677 at standard doses already raises concerns about water retention, insulin resistance, and elevated fasting glucose. Kanaley et al. (2008, Journal of Clinical Endocrinology and Metabolism) noted glucose metabolism effects at therapeutic GH secretagogue doses. Tripling a dose compounds those risks without any corresponding evidence of benefit.
The appetite suppression side effect from semax is also worth naming directly. It is a known phenomenon and not discussed enough in biohacking communities. Ignoring it and overriding it with another compound is not a solution.
What should you actually know?
If you are using semax and losing your appetite, that is a signal worth paying attention to, not routing around with a higher dose of a different drug. Appetite suppression from peptides or nootropics can reflect real physiological stress, not just an inconvenience.
MK-677 is frequently discussed as if it is benign because it is not an injectable peptide and is sold as a research chemical. It is not benign. Long-term GH secretagogue use in healthy adults has not been adequately studied for safety. The compound has shown promise in specific clinical contexts, including muscle wasting in older adults (Chapman et al., 1996, Journal of Clinical Endocrinology and Metabolism), but those populations and doses are not the same as a healthy adult self-dosing for performance.
Semax remains unapproved by the FDA for any indication. It is legal to purchase as a research chemical in the US but is not approved for human use outside Russia and Ukraine. Anyone stacking it with MK-677 and adjusting doses based on how their sales calls are going is operating well outside any framework of clinical oversight.
The bottom line
The cognitive benefits the creator describes for semax are biologically plausible, but the evidence in healthy adults doing cognitively demanding work is weak. The decision to triple MK-677 in response to appetite suppression is the part that genuinely concerns us. That is not a strategy, it is improvisation with compounds that affect GH axis regulation and glucose metabolism. If you are experiencing significant appetite changes on any peptide regimen, that is a conversation for a clinician, not a dose adjustment you make on your own.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax side effects: what TikTok gets wrong about nasal irritation, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Semax side effects: what TikTok gets wrong about nasal irritation should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
The creator is stacking semax, a synthetic ACTH-derived peptide with dopaminergic and BDNF-related activity, with MK-677, a non-peptide ghrelin mimetic and GH secretagogue.
FormBlends verdict
The creator is stacking semax, a synthetic ACTH-derived peptide with dopaminergic and BDNF-related activity, with MK-677, a non-peptide ghrelin mimetic and GH secretagogue. They are reporting appetite suppression as a side effect of the stack and responding by self-escalating their MK-677 dose, a pharmacologically unsupported approach that raises concerns about insulin sensitivity and GH axis dysregulation. Neither compound is FDA-approved for the uses described, and this stack has no published safety data in healthy adults.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator is stacking semax, a synthetic ACTH-derived peptide with dopaminergic and BDNF-related activity, with MK-677, a non-peptide ghrelin mimetic and GH secretagogue. They are reporting appetite suppression as a side effect of the stack and responding by self-escalating their MK-677 dose, a pharmacologically unsupported approach that raises concerns about insulin sensitivity and GH axis dysregulation. Neither compound is FDA-approved for the uses described, and this stack has no published safety data in healthy adults.
- Semax is a synthetic heptapeptide studied primarily in Russia for stroke and cognitive applications, with no FDA approval for any indication in the US.
- Animal and limited human data (Bobyntsev et al., 2015) support semax's effects on BDNF and dopamine signaling, but no controlled study has tested it for sales performance in healthy adults.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax is a synthetic heptapeptide studied primarily in Russia for stroke and cognitive applications, with no FDA approval for any indication in the US.
- Animal and limited human data (Bobyntsev et al., 2015) support semax's effects on BDNF and dopamine signaling, but no controlled study has tested it for sales performance in healthy adults.
- MK-677 raises fasting glucose and affects insulin sensitivity even at standard doses. Kanaley et al. (2008) documented GH secretagogue effects on glucose metabolism, making unsupervised dose escalation genuinely risky.
- Appetite suppression from semax is a real, underreported side effect. Ignoring it by layering in more of a second compound is not a clinically supported strategy.
- MK-677 is not a peptide. It is a small-molecule ghrelin mimetic and GH secretagogue, often grouped with peptides in biohacking communities but operating through a distinct mechanism.
- Tripling any GH secretagogue dose based on personal observation violates basic principles of pharmacological safety and has no support in published literature.
- Anyone experiencing significant appetite changes, body composition shifts, or cognitive effects from an unsupervised peptide stack should consult a clinician before adjusting doses.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Rivi · TikTok creator
13.0K views on this video
Fr the only bad part. Anyone know how to fix this? #semax #nootropics #biohacking #peptide #salesman
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Rivi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.